Drug Discovery 2022: driving the next life science revolution
WuXi AppTec
Where: C5 [Show on Floor Plan]
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2021 and its open-access platform is enabling more than 5,800 collaborators from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."
Tel: +1 (888) 794-0077
Address: 5 New Street Square
London
Website: http://www.wuxiapptec.com/
Email:

Presentations at Drug Discovery 2022: driving the next life science revolution

Wed5  Oct12:35pm(15 mins)
Room: Auditorium 2

Staff Attending

Mrs Ambreen Anwer
Business Development Manager
WuXi AppTec